newsfilter
← Latest News
Business Wire·

Gamida Cell Reports First Quarter 2023 Financial Results and Provides Company Update

Company reports positive feedback and continued progress on transplant center onboarding and payer coverage around launch of Omisirge® (omidubicel-onlv), a new cell therapy for allogeneic stem cell transplant